Published in Int Urogynecol J on January 19, 2012
The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol (1996) 21.06
Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol (2001) 4.83
The demographics of pelvic floor disorders: current observations and future projections. Am J Obstet Gynecol (2001) 4.06
Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev (2010) 3.64
Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol (2001) 3.03
Anal incontinence and bowel dysfunction after sacrocolpopexy for vaginal vault prolapse. Int Urogynecol J (2010) 2.05
Pelvic symptoms in women with pelvic organ prolapse. Obstet Gynecol (2004) 1.91
Posterior vaginal prolapse and bowel function. Am J Obstet Gynecol (1998) 1.46
Laparoscopic sacrocolpopexy for uterine and post-hysterectomy prolapse: anatomical results, quality of life and perioperative outcome-a prospective study with 101 cases. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.39
A 25-year experience with 519 anterior colporrhaphy procedures. Obstet Gynecol (1991) 1.34
Fecal incontinence in women with urinary incontinence and pelvic organ prolapse. Obstet Gynecol (1997) 1.17
Prevalence of anal incontinence in women with symptoms of urinary incontinence and genital prolapse. Obstet Gynecol (2002) 1.17
Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am J Epidemiol (2004) 1.17
Functional results and quality-of-life after bilateral sacrospinous ligament fixation for genital prolapse. Eur J Obstet Gynecol Reprod Biol (2006) 1.15
Patterns of constipation in urogynecology: clinical importance and pathophysiologic insights. Am J Obstet Gynecol (2006) 1.10
Posterior vaginal wall prolapse does not correlate with fecal symptoms or objective measures of anorectal function. Am J Obstet Gynecol (2006) 1.05
Bowel symptoms in women planning surgery for pelvic organ prolapse. Am J Obstet Gynecol (2006) 1.02
Long-term outcome of vaginal sacrospinous colpopexy for marked uterovaginal and vault prolapse. Eur J Obstet Gynecol Reprod Biol (2005) 1.02
A prospective study of laparoscopic sacrocolpopexy for the management of pelvic organ prolapse. BJOG (2009) 0.92
Colorectal and anal symptoms in women with urinary incontinence and pelvic organ prolapse. Int Urogynecol J (2009) 0.85
Feasibility and functional outcome of laparoscopic sacrocolporectopexy for combined vaginal and rectal prolapse. Dis Colon Rectum (2008) 0.84
Bowel, bladder and sexual function in women undergoing laparoscopic posterior compartment repair in the presence of apical or anterior compartment dysfunction. Aust N Z J Obstet Gynaecol (2005) 0.81
Factors associated with symptoms of pelvic floor dysfunction six years after primary operation of genital prolapse. Acta Obstet Gynecol Scand (2008) 0.78
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol (2006) 7.24
Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol (2004) 4.51
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer. J Clin Oncol (2005) 4.03
Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol (2011) 2.35
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol (2005) 2.07
Trends in the rate of invasive procedures after the addition of the intrauterine tamponade test to a protocol for management of severe postpartum hemorrhage. Am J Obstet Gynecol (2012) 2.04
The survival impact of systematic lymphadenectomy in endometrial cancer with the use of propensity score matching analysis. Am J Obstet Gynecol (2012) 2.01
Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Ann Surg Oncol (2011) 1.83
Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol (2009) 1.77
Randomized trial of laparoscopically assisted versus open colorectal resection for endometriosis: morbidity, symptoms, quality of life, and fertility. Ann Surg (2010) 1.74
Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis. Fertil Steril (2008) 1.72
External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Gynecol Oncol (2008) 1.71
Quality of life after laparoscopic colorectal resection for endometriosis. Hum Reprod (2006) 1.66
Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol (2008) 1.54
Prospective multicenter comparison of models to predict four or more involved axillary lymph nodes in patients with breast cancer with one to three metastatic sentinel lymph nodes. J Clin Oncol (2009) 1.48
Ovarian recurrence after radical trachelectomy for adenocarcinoma of the cervix. Am J Obstet Gynecol (2005) 1.45
Prospective comparison of clinical and genomic multivariate predictors of response to neoadjuvant chemotherapy in breast cancer. Clin Cancer Res (2010) 1.44
Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol (2007) 1.44
Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. Am J Obstet Gynecol (2010) 1.43
Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma. Cancer (2005) 1.40
Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg (2003) 1.40
Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy. J Clin Oncol (2005) 1.33
Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer (2010) 1.31
Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol (2011) 1.29
Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial. J Clin Oncol (2009) 1.25
Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response. Cancer (2004) 1.22
Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. Radiology (2010) 1.19
Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol (2009) 1.18
Body mass index and outcome of tension-free vaginal tape. Eur Urol (2003) 1.16
Functional results and quality-of-life after bilateral sacrospinous ligament fixation for genital prolapse. Eur J Obstet Gynecol Reprod Biol (2006) 1.15
The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma. PLoS One (2011) 1.14
Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and müllerian duct abnormalities: a French collaborative study. J Clin Endocrinol Metab (2008) 1.12
Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging (2008) 1.12
Determinants of pregnancy rate in the donor oocyte model: a multivariate analysis of 450 frozen-thawed embryo transfers. Hum Reprod (2009) 1.10
Anaphylactic response to blue dye during sentinel lymph node biopsy. Surg Oncol (2010) 1.10
Risks associated with laparoscopic entry: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol (2011) 1.10
Outcome of laparoscopic colorectal resection for endometriosis. Curr Opin Obstet Gynecol (2007) 1.10
Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer. J Clin Oncol (2010) 1.09
Genomic profile of breast cancer. Expert Rev Pharmacoecon Outcomes Res (2015) 1.09
How soon can I be proficient in embryo transfer? Lessons from the cumulative summation test for learning curve (LC-CUSUM). Hum Reprod (2009) 1.08
Breast cancer stroma frequently recruits fetal derived cells during pregnancy. Breast Cancer Res (2008) 1.07
Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Radiology (2008) 1.06
Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol (2004) 1.05
Value of magnetic resonance imaging for the diagnosis of ovarian tumors: a review. J Comput Assist Tomogr (2008) 1.03
Anal fissure and thrombosed external hemorrhoids before and after delivery. Dis Colon Rectum (2002) 1.02
Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer (2004) 1.02
Ductal carcinoma in situ: value of sentinel lymph node biopsy. J Surg Oncol (2006) 1.01
Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique. Int J Gynecol Cancer (2011) 1.00
Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study. Int J Gynecol Cancer (2012) 0.99
Malignant female adnexal tumor of probable wolffian origin relapsing after pregnancy. Gynecol Oncol (2004) 0.98
Ultrastaging of lymph node in uterine cancers. J Exp Clin Cancer Res (2010) 0.98
Treatment of genital prolapse by hammock using porcine skin collagen implant (Pelvicol). Urology (2005) 0.96
Pregnancy-associated breast cancers: do they differ from other breast cancers in young women? Breast (2012) 0.96
Immediate reconstruction after neoadjuvant chemotherapy: effect on adjuvant treatment starting and survival. Ann Surg Oncol (2005) 0.96
Increased fetal cell microchimerism in high grade breast carcinomas occurring during pregnancy. Int J Cancer (2009) 0.96
A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. Am J Obstet Gynecol (2012) 0.96
Urinary complications after surgery for posterior deep infiltrating endometriosis are related to the extent of dissection and to uterosacral ligaments resection. J Minim Invasive Gynecol (2008) 0.96
Accuracy of magnetic resonance imaging and rectal endoscopic sonography for the prediction of location of deep pelvic endometriosis. Hum Reprod (2007) 0.95
How to differentiate benign from malignant myometrial tumours using MR imaging. Eur Radiol (2013) 0.95
Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril (2005) 0.95
Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours. J Surg Oncol (2005) 0.94
Laparoscopic radical hysterectomy for invasive cervical cancer: 8-year experience of a pilot study. Gynecol Oncol (2003) 0.93
Four-year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World J Urol (2011) 0.92
Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study. Breast Cancer Res Treat (2008) 0.92
Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers. Clin Cancer Res (2011) 0.92
Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer. Gynecol Oncol (2005) 0.92
Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors. Am J Obstet Gynecol (2008) 0.92
MR imaging compared with intraoperative frozen-section examination for the diagnosis of adnexal tumors; correlation with final histology. Eur Radiol (2006) 0.91
Spontaneous rectovaginal fistula during bevacizumab therapy for ovarian cancer: a case report. Am J Obstet Gynecol (2009) 0.91
Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study. Eur Radiol (2011) 0.91
Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus. Clin Cancer Res (2003) 0.90
[Somatostatin in breast cancer]. Ann Biol Clin (Paris) (2011) 0.90
Tattooing breast cancers treated with neoadjuvant chemotherapy. Ann Surg Oncol (2007) 0.90
Genital prolapse repair using porcine skin implant and bilateral sacrospinous fixation: midterm functional outcome and quality-of-life assessment. Urology (2008) 0.90
Sexual and functional results after creation of a neovagina in women with Mayer-Rokitansky-Küster-Hauser syndrome: a comparison of nonsurgical and surgical procedures. Eur J Obstet Gynecol Reprod Biol (2013) 0.90
Expression of cadherins and CD44 isoforms in human endometrium and peritoneal endometriosis. Acta Obstet Gynecol Scand (2002) 0.89
Effects of progesterone and anti-progestin (mifepristone) treatment on proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3. Oncol Rep (2006) 0.89
Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2. Int J Oncol (2008) 0.89